Annalisa Di Ruscio, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Methylation | 13 | 2023 | 4384 | 1.280 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 5 | 2021 | 286 | 0.840 |
Why?
|
| NAD | 1 | 2021 | 612 | 0.580 |
Why?
|
| Cell Differentiation | 10 | 2021 | 11512 | 0.520 |
Why?
|
| Epigenesis, Genetic | 5 | 2023 | 3788 | 0.510 |
Why?
|
| Gene Expression Regulation, Leukemic | 7 | 2021 | 651 | 0.450 |
Why?
|
| RNA | 1 | 2023 | 2709 | 0.420 |
Why?
|
| RNA, Untranslated | 1 | 2013 | 453 | 0.340 |
Why?
|
| Promoter Regions, Genetic | 11 | 2021 | 5773 | 0.340 |
Why?
|
| Induced Pluripotent Stem Cells | 4 | 2020 | 1852 | 0.330 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2021 | 426 | 0.330 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2021 | 355 | 0.320 |
Why?
|
| Leukemia, Myeloid, Acute | 8 | 2021 | 3610 | 0.280 |
Why?
|
| Myeloid Cells | 5 | 2021 | 822 | 0.250 |
Why?
|
| Hematopoietic Stem Cells | 6 | 2021 | 3390 | 0.230 |
Why?
|
| Core Binding Factor beta Subunit | 1 | 2021 | 42 | 0.200 |
Why?
|
| Trans-Activators | 3 | 2021 | 2846 | 0.200 |
Why?
|
| Cadherins | 2 | 2021 | 902 | 0.190 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2021 | 50 | 0.190 |
Why?
|
| Hemopexin | 1 | 2020 | 33 | 0.180 |
Why?
|
| GATA2 Transcription Factor | 1 | 2021 | 158 | 0.180 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2015 | 686 | 0.170 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 3222 | 0.170 |
Why?
|
| Oxidative Phosphorylation | 1 | 2021 | 495 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2021 | 4513 | 0.160 |
Why?
|
| Calcineurin | 1 | 2019 | 229 | 0.160 |
Why?
|
| Heme | 1 | 2020 | 313 | 0.150 |
Why?
|
| Neoplasms | 4 | 2021 | 22142 | 0.150 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 2021 | 1605 | 0.150 |
Why?
|
| Genomic Imprinting | 1 | 2019 | 323 | 0.150 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2019 | 550 | 0.150 |
Why?
|
| Genes, abl | 2 | 2015 | 69 | 0.140 |
Why?
|
| Cell Line | 4 | 2021 | 15545 | 0.140 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 11855 | 0.140 |
Why?
|
| Transcription, Genetic | 4 | 2021 | 7571 | 0.130 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 634 | 0.130 |
Why?
|
| CpG Islands | 2 | 2019 | 1190 | 0.130 |
Why?
|
| Azacitidine | 3 | 2015 | 336 | 0.130 |
Why?
|
| Myelodysplastic Syndromes | 3 | 2011 | 1393 | 0.130 |
Why?
|
| Core Binding Factor alpha Subunits | 1 | 2014 | 25 | 0.120 |
Why?
|
| RNA, Messenger | 4 | 2021 | 12747 | 0.120 |
Why?
|
| Leukemia, Myeloid | 2 | 2007 | 693 | 0.110 |
Why?
|
| SOXC Transcription Factors | 1 | 2013 | 41 | 0.110 |
Why?
|
| Epigenomics | 1 | 2019 | 944 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2021 | 1967 | 0.110 |
Why?
|
| Astrocytes | 1 | 2019 | 1341 | 0.100 |
Why?
|
| Genome | 1 | 2019 | 1738 | 0.090 |
Why?
|
| Protein Kinase C | 1 | 2016 | 1202 | 0.090 |
Why?
|
| Cell Lineage | 2 | 2021 | 2549 | 0.090 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 2 | 2009 | 130 | 0.090 |
Why?
|
| Granulocytes | 2 | 2012 | 550 | 0.080 |
Why?
|
| Teratoma | 1 | 2012 | 404 | 0.080 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2010 | 127 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2023 | 8531 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2013 | 1768 | 0.080 |
Why?
|
| Stem Cells | 2 | 2020 | 3517 | 0.080 |
Why?
|
| Neoplastic Stem Cells | 3 | 2014 | 1348 | 0.080 |
Why?
|
| Interleukin-6 | 2 | 2016 | 3210 | 0.080 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2010 | 489 | 0.080 |
Why?
|
| Thrombospondin 1 | 1 | 2010 | 257 | 0.080 |
Why?
|
| Mitochondria | 1 | 2021 | 3620 | 0.080 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2007 | 5 | 0.070 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2007 | 4 | 0.070 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2009 | 249 | 0.070 |
Why?
|
| Oleanolic Acid | 1 | 2007 | 43 | 0.070 |
Why?
|
| Polymorphism, Genetic | 2 | 2008 | 4243 | 0.070 |
Why?
|
| Base Sequence | 2 | 2019 | 12404 | 0.070 |
Why?
|
| Myocytes, Cardiac | 1 | 2016 | 1666 | 0.070 |
Why?
|
| Hippocampus | 1 | 2019 | 3754 | 0.070 |
Why?
|
| Glutathione Transferase | 2 | 2007 | 564 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 2864 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 9417 | 0.070 |
Why?
|
| DNA Repair Enzymes | 1 | 2007 | 346 | 0.060 |
Why?
|
| Humans | 25 | 2021 | 761222 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2021 | 6125 | 0.060 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 1141 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 1855 | 0.060 |
Why?
|
| DNA | 2 | 2020 | 7189 | 0.060 |
Why?
|
| Isoenzymes | 2 | 2007 | 1682 | 0.060 |
Why?
|
| Animals | 13 | 2021 | 168089 | 0.060 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 16954 | 0.060 |
Why?
|
| Hematopoiesis | 1 | 2012 | 2049 | 0.050 |
Why?
|
| Cells, Cultured | 5 | 2021 | 18927 | 0.050 |
Why?
|
| U937 Cells | 2 | 2015 | 260 | 0.050 |
Why?
|
| Neoplasms, Second Primary | 1 | 2010 | 1052 | 0.050 |
Why?
|
| Antisense Elements (Genetics) | 1 | 2021 | 37 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2016 | 23419 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2009 | 2410 | 0.050 |
Why?
|
| Genome, Human | 1 | 2013 | 4423 | 0.040 |
Why?
|
| K562 Cells | 2 | 2015 | 640 | 0.040 |
Why?
|
| Cytokines | 1 | 2015 | 7386 | 0.040 |
Why?
|
| BRCA1 Protein | 1 | 2006 | 1149 | 0.040 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2020 | 325 | 0.040 |
Why?
|
| Mice, Knockout | 4 | 2019 | 14392 | 0.040 |
Why?
|
| DNA Repair | 1 | 2008 | 2041 | 0.040 |
Why?
|
| Protein Binding | 3 | 2019 | 9297 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2013 | 2010 | 0.040 |
Why?
|
| Gene Fusion | 1 | 2021 | 355 | 0.040 |
Why?
|
| Gliosis | 1 | 2019 | 245 | 0.040 |
Why?
|
| Basophils | 1 | 2021 | 407 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2010 | 3671 | 0.040 |
Why?
|
| Chromosomes, Human | 1 | 2020 | 442 | 0.040 |
Why?
|
| G-Quadruplexes | 1 | 2020 | 143 | 0.040 |
Why?
|
| Antigens, CD34 | 2 | 2011 | 655 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2014 | 5666 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 11101 | 0.040 |
Why?
|
| Alleles | 1 | 2008 | 6857 | 0.040 |
Why?
|
| Hodgkin Disease | 1 | 2005 | 1379 | 0.040 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2019 | 476 | 0.030 |
Why?
|
| Methylation | 1 | 2019 | 1070 | 0.030 |
Why?
|
| HL-60 Cells | 2 | 2007 | 363 | 0.030 |
Why?
|
| Ventricular Myosins | 1 | 2016 | 65 | 0.030 |
Why?
|
| Cell Proliferation | 3 | 2020 | 10423 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2021 | 1749 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 987 | 0.030 |
Why?
|
| Mice | 7 | 2021 | 81330 | 0.030 |
Why?
|
| Lysine | 1 | 2019 | 982 | 0.030 |
Why?
|
| Base Pairing | 1 | 2014 | 139 | 0.030 |
Why?
|
| Mast Cells | 1 | 2021 | 1392 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3777 | 0.030 |
Why?
|
| Luciferases, Renilla | 1 | 2012 | 21 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4567 | 0.030 |
Why?
|
| Cerebellum | 1 | 2019 | 1501 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2020 | 2926 | 0.020 |
Why?
|
| DNA Modification Methylases | 1 | 2012 | 210 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2020 | 2881 | 0.020 |
Why?
|
| Lung | 1 | 2010 | 9979 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2015 | 1334 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2012 | 4111 | 0.020 |
Why?
|
| Hematology | 1 | 2014 | 243 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 9520 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2016 | 3577 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 848 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2012 | 629 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 4909 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 3 | 2014 | 22128 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2008 | 5032 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2452 | 0.020 |
Why?
|
| Calgranulin A | 1 | 2009 | 80 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1602 | 0.020 |
Why?
|
| Histones | 1 | 2019 | 2570 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2012 | 1518 | 0.020 |
Why?
|
| Xenobiotics | 1 | 2008 | 70 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2012 | 790 | 0.020 |
Why?
|
| Antigens, CD | 2 | 2010 | 4009 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2012 | 1822 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2009 | 5871 | 0.020 |
Why?
|
| Oncogenes | 1 | 2013 | 1220 | 0.020 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2007 | 56 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2010 | 651 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2012 | 2621 | 0.020 |
Why?
|
| Leukopenia | 1 | 2008 | 213 | 0.020 |
Why?
|
| Mutation | 3 | 2019 | 30004 | 0.020 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2007 | 113 | 0.020 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2011 | 646 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2012 | 1329 | 0.020 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2007 | 112 | 0.020 |
Why?
|
| Rad51 Recombinase | 1 | 2007 | 189 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2007 | 112 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2008 | 282 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2008 | 6819 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2007 | 177 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 5988 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2009 | 726 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2007 | 413 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2006 | 739 | 0.020 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2005 | 99 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2012 | 2603 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 2381 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2020 | 3758 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2011 | 2706 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2005 | 765 | 0.010 |
Why?
|
| Male | 9 | 2020 | 360703 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 2011 | 58952 | 0.010 |
Why?
|
| Aged | 7 | 2011 | 169292 | 0.010 |
Why?
|
| Disease Progression | 1 | 2020 | 13511 | 0.010 |
Why?
|
| Adolescent | 5 | 2011 | 88300 | 0.010 |
Why?
|
| Survival Rate | 2 | 2008 | 12728 | 0.010 |
Why?
|
| Phenotype | 1 | 2020 | 16575 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2010 | 2159 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2007 | 3603 | 0.010 |
Why?
|
| Neurons | 1 | 2019 | 9429 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2008 | 22174 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2007 | 2091 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2020 | 26200 | 0.010 |
Why?
|
| Neutrophils | 1 | 2012 | 3763 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2006 | 1500 | 0.010 |
Why?
|
| Rats | 1 | 2016 | 23705 | 0.010 |
Why?
|
| Middle Aged | 6 | 2011 | 220858 | 0.010 |
Why?
|
| Adult | 6 | 2011 | 221120 | 0.010 |
Why?
|
| Female | 8 | 2011 | 392552 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 4744 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 2916 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6486 | 0.010 |
Why?
|
| Gene Expression | 1 | 2011 | 7571 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2020 | 64681 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2010 | 3552 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2007 | 8300 | 0.010 |
Why?
|
| Acute Disease | 1 | 2006 | 7226 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 6067 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2012 | 10203 | 0.010 |
Why?
|
| Risk Factors | 2 | 2008 | 74241 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 12985 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 9567 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 41496 | 0.000 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2005 | 15920 | 0.000 |
Why?
|
| Young Adult | 1 | 2011 | 59222 | 0.000 |
Why?
|
| Prognosis | 1 | 2005 | 29688 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2005 | 17897 | 0.000 |
Why?
|